Trial
NCT00461773
Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Yale University
Collaborators
Novartis; Genentech, Inc.
Condition
Hormone-Sensitive Breast Cancer
Intervention
Letrozole
Why stopped
Lack of recrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-16